Evidence map›Paper›PMID 25954524›Full record

ReviewInternational journal of medicinal chemistry2012

Current updates on oxazolidinone and its significance.

Neha Pandit, Rajeev K Singla, Birendra Shrivastava

Abstract readReview
In one paragraph

Review in International journal of medicinal chemistry, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed.

  1. Article
  2. A Material Platform Based on Dissociative COJournal of the American Chemical Society · 2025
    Article
  3. Article
  4. Cyclic Isothiocyanate Goitrin ImpairsPlants (Basel, Switzerland) · 2024
    Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Antimicrobial Effects of Biogenic Nanoparticles.Nanomaterials (Basel, Switzerland) · 2018
    Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Neha PanditDepartment of Pharmaceutical Chemistry, School of Pharmaceutical Sciences, Jaipur National University, Jagatpura-Jaipur, Rajasthan 302025, India.
Rajeev K SinglaSadbhavna College of Management & Technology, Jalaldiwal, Ludhiana-Barnala State Highway-13, Raikot (Ludhiana), Punjab, India.
Birendra ShrivastavaDepartment of Pharmaceutical Chemistry, School of Pharmaceutical Sciences, Jaipur National University, Jagatpura-Jaipur, Rajasthan 302025, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Oxazolidinone is a five-member heterocyclic ring exhibiting potential medicinal properties with preferential antibacterial activity. Scientists reported various synthetic procedures for this heterocyclic structure. Current review articles tried to cover each and every potential aspect of oxazolidinone like synthetic routes, pharmacological mechanism of action, medicinal properties, and current research activities.

Identifiers

PMID25954524
PMCPMC4412212

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.